From morning til night, we never stop executing movements at the right time and speed. But patients suffering from Parkinson's disease lose this natural control over their voluntary movements.
Jan 31, 2018
0
917
Standard drug treatment for Parkinson's disease can over time induce motor complications that reduce the effectiveness of restoring mobility. These complications include abnormal involuntary movements known as dyskinesias. ...
Jan 25, 2018
0
30
Blocking a nerve-cell receptor in part of the brain that coordinates movement could improve the treatment of Parkinson's disease, dyskinesia and other movement disorders, researchers at Vanderbilt University have reported.
Jan 19, 2018
0
8
Recreational drug use during adolescence may disrupt development of an understudied part of the prefrontal cortex, according to a study of male mice published in eNeuro.
Jan 8, 2018
0
4
While vigorous exercise on a treadmill has been shown to slow the progression of Parkinson's disease in patients, the molecular reasons behind it have remained a mystery.
Dec 22, 2017
0
858
(HealthDay)—Use of dopaminergic antagonists and agonists can affect blood pressure (BP), according to a review published online Nov. 8 in the Journal of Clinical Pharmacy and Therapeutics.
Dec 9, 2017
0
1
Restless sleep could be a sign of a disorder associated with diseases of the brain. Researchers from Aarhus University conducted a case-control study on the condition of the dopamine-producing nerve cells in the brain and ...
Dec 6, 2017
0
1
Drug addiction may not require a habitual relationship with a substance, suggests findings from a new model of cocaine administration in rats that better captures the human experience of obtaining and using drugs. The research, ...
Nov 20, 2017
0
1
New research provides fresh insight into how the brain processes reward and punishment, opening new avenues for developing treatment of conditions ranging from anxiety to addictive behaviors such as drug abuse.
Nov 10, 2017
0
318
Oxidative stress plays a big role in the brain cell loss that occurs in Parkinson's disease. Now scientists have their sights on a protein that inhibits one of the body's natural protections against it.
Nov 6, 2017
0
106
